LRP5 and central nervous system cancer: <b>Conclusion:</b> This research has identified that LRP5 may promote glioma proliferation by influencing the G2/M transition and the activation of the MAPK/p53/cdc2 pathways, suggesting its value as a potential molecular target for glioma diagnosis and treatment.